Wei Jin1, Qiumin Wu2, Zhiwei He3, Yilan Fu1. 1. Department of Endocrinology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University Haikou 570311, Hainan, China. 2. Department of Outpatient, Hainan Cancer Hospital Haikou 570311, Hainan, China. 3. Department of Radiology, Hainan Cancer Hospital Haikou 570311, Hainan, China.
Abstract
OBJECTIVE: This study was designed to investigate the effects of cognitive-behavioral intervention (CBI) combined with integrated health care (IHC) on glycemic control, adverse mood, health knowledge and self-efficacy in patients with type 2 diabetes mellitus. METHODS: The clinical data of 115 patients with type 2 diabetes mellitus were retrospectively collected and divided into two groups according to the intervention methods, with 57 patients in group A receiving conventional care and 58 patients in group B receiving CBI combined with IHC. The blood glucose, scores of Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A), health knowledge, self-efficacy, quality of life, and nursing satisfaction were compared between the two groups before and after intervention. RESULTS: Compared with group A, group B had lower glycated hemoglobin (HbAlc), 2-h postprandial glucose (2 hPG), and fasting plasma glucose (FPG) levels (P < 0.05), lower HAMD and HAMA scores (P < 0.05), higher health knowledge and self-efficacy scores (P < 0.05), and higher quality of life after intervention (P < 0.05). Group B exhibited a nursing satisfaction rate of 94.83%, higher than that of 70.18% in group A (P < 0.05). CONCLUSION: The effects of CBI combined with IHC can effectively control blood glucose and improve dysphoria, health knowledge, self-efficacy, and quality of life in patients with type 2 diabetes. AJTR
OBJECTIVE: This study was designed to investigate the effects of cognitive-behavioral intervention (CBI) combined with integrated health care (IHC) on glycemic control, adverse mood, health knowledge and self-efficacy in patients with type 2 diabetes mellitus. METHODS: The clinical data of 115 patients with type 2 diabetes mellitus were retrospectively collected and divided into two groups according to the intervention methods, with 57 patients in group A receiving conventional care and 58 patients in group B receiving CBI combined with IHC. The blood glucose, scores of Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A), health knowledge, self-efficacy, quality of life, and nursing satisfaction were compared between the two groups before and after intervention. RESULTS: Compared with group A, group B had lower glycated hemoglobin (HbAlc), 2-h postprandial glucose (2 hPG), and fasting plasma glucose (FPG) levels (P < 0.05), lower HAMD and HAMA scores (P < 0.05), higher health knowledge and self-efficacy scores (P < 0.05), and higher quality of life after intervention (P < 0.05). Group B exhibited a nursing satisfaction rate of 94.83%, higher than that of 70.18% in group A (P < 0.05). CONCLUSION: The effects of CBI combined with IHC can effectively control blood glucose and improve dysphoria, health knowledge, self-efficacy, and quality of life in patients with type 2 diabetes. AJTR
Authors: Amir Qaseem; Timothy J Wilt; Devan Kansagara; Carrie Horwitch; Michael J Barry; Mary Ann Forciea; Nick Fitterman; Kate Balzer; Cynthia Boyd; Linda L Humphrey; Alfonso Iorio; Jennifer Lin; Michael Maroto; Robert McLean; Reem Mustafa; Janice Tufte Journal: Ann Intern Med Date: 2018-03-06 Impact factor: 25.391
Authors: P A Dyson; D Twenefour; C Breen; A Duncan; E Elvin; L Goff; A Hill; P Kalsi; N Marsland; P McArdle; D Mellor; L Oliver; K Watson Journal: Diabet Med Date: 2018-05 Impact factor: 4.359
Authors: Khalida Ismail; Kirsty Winkley; Nicole de Zoysa; Anita Patel; Margaret Heslin; Helen Graves; Stephen Thomas; Dominic Stringer; Daniel Stahl; Stephanie A Amiel Journal: Br J Gen Pract Date: 2018-07-16 Impact factor: 5.386
Authors: J Cárdenas-Valladolid; A López-de Andrés; R Jiménez-García; M J de Dios-Duarte; P Gómez-Campelo; C de Burgos-Lunar; F J San Andrés-Rebollo; J C Abánades-Herranz; M A Salinero-Fort Journal: BMC Fam Pract Date: 2018-07-24 Impact factor: 2.497